Clinical Trial Update: Clinical Trial to Evaluate the Efficacy and Safety of YHP2401 Compared to YHR2402 and YHR2403 for Acute Bronchitis [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating the efficacy and safety of YHP2401 compared with YHR2402 and YHR2403 for acute bronchitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchitis

Drugs mentioned

• YHP2401
• YHR2402
• YHR2403

Snippet

Sponsor: Yuhan Corporation | Conditions: Acute Bronchitis | Phase 3 | Status: COMPLETED